FR14C0042I1 - Implant injectable a liberation prolongee comprenant un noyau a matrice bioerodable et un revetement bioerodable - Google Patents

Implant injectable a liberation prolongee comprenant un noyau a matrice bioerodable et un revetement bioerodable

Info

Publication number: FR14C0042I1
Authority: FR; France
Prior art keywords: drug; core; bioerodable; skin; polymer
Prior art date: 2003-11-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR14C0042C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eyepoint Pharmaceuticals Inc

Eyepoint Pharmaceuticals US Inc

Original Assignee

Psivida US Inc

Psivida Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-13

Filing date

2014-05-20

Publication date

2014-06-27

2003-11-13 Priority claimed from US10/714,549 external-priority patent/US8871241B2/en

2014-05-20 Application filed by Psivida US Inc, Psivida Inc filed Critical Psivida US Inc

2014-06-27 Publication of FR14C0042I1 publication Critical patent/FR14C0042I1/fr

Status Active legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Hematology (AREA)
Obesity (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Molecular Biology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Prostheses (AREA)

FR14C0042C 2003-11-13 2014-05-20 Implant injectable a liberation prolongee comprenant un noyau a matrice bioerodable et un revetement bioerodable Active FR14C0042I1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US10/714,549 US8871241B2 (en)	2002-05-07	2003-11-13	Injectable sustained release delivery devices
US54336804P	2004-02-09	2004-02-09
EP04796413A EP1696822B1 (en)	2003-11-13	2004-10-26	Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin

Publications (1)

Publication Number	Publication Date
FR14C0042I1 true FR14C0042I1 (fr)	2014-06-27

Family

ID=34636703

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR14C0042C Active FR14C0042I1 (fr)	2003-11-13	2014-05-20	Implant injectable a liberation prolongee comprenant un noyau a matrice bioerodable et un revetement bioerodable

Country Status (20)

Country	Link
EP (2)	EP2233112B3 (pt)
JP (3)	JP5661226B2 (pt)
AT (1)	ATE460901T1 (pt)
AU (1)	AU2004292957C1 (pt)
CA (1)	CA2545650C (pt)
CY (1)	CY1114947T1 (pt)
DE (1)	DE602004026106D1 (pt)
DK (1)	DK1696822T3 (pt)
ES (2)	ES2447816T7 (pt)
FR (1)	FR14C0042I1 (pt)
HK (1)	HK1148931A1 (pt)
IL (1)	IL175584A (pt)
MX (1)	MXPA06005431A (pt)
NO (1)	NO20062362L (pt)
NZ (3)	NZ575950A (pt)
PL (2)	PL1696822T3 (pt)
PT (2)	PT2233112E (pt)
SI (1)	SI1696822T1 (pt)
TW (2)	TWI445559B (pt)
WO (1)	WO2005051234A2 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6375972B1 (en)	2000-04-26	2002-04-23	Control Delivery Systems, Inc.	Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
DK1696822T3 (da)	2003-11-13	2010-05-17	Psivida Inc	Injicerbart vedvarende frigørelsesimplantat, som har en bioeroderbar matrixkerne og en bioeroderbar hus
CA2572592C (en)	2004-07-02	2015-09-08	Eliot Lazar	Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device
WO2007076358A1 (en) *	2005-12-23	2007-07-05	Alcon, Inc.	PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
CN103393483B (zh)	2006-03-31	2016-08-24	玛提治疗有限公司	用于鼻泪系统的药物释放方法、结构及组合物
NZ578664A (en)	2007-06-08	2011-11-25	Boehringer Ingelheim Int	Extended release formulation of nevirapine
WO2009035571A2 (en)	2007-09-07	2009-03-19	Qlt Plug Delivery, Inc	Lacrimal implant detection
FR2927798B1 (fr) *	2008-02-25	2011-03-04	C L Investissements	Procede de fabrication d'un dispositif contraceptif intra-uterin et installation pour la mise en oeuvre de ce procede
US8858983B2 (en)	2009-04-30	2014-10-14	Medtronic, Inc.	Antioxidants and antimicrobial accessories including antioxidants
EP2515864A4 (en) *	2009-12-23	2013-09-11	Psivida Inc	DELAYED RELEASE DELIVERY DEVICES
US20130017243A1 (en) *	2010-04-06	2013-01-17	Allergan, Inc.	Sustained-release reservoir implants for intracameral drug delivery
WO2011146483A1 (en)	2010-05-17	2011-11-24	Aerie Pharmaceuticals, Inc.	Drug delivery devices for delivery of ocular therapeutic agents
US8911427B2 (en)	2010-12-28	2014-12-16	Medtronic, Inc.	Therapeutic agent reservoir delivery system
US20120207682A1 (en) *	2011-02-11	2012-08-16	Psivida Us, Inc.	Methods of treating macular edema using antiedema therapeutics
US9974685B2 (en)	2011-08-29	2018-05-22	Mati Therapeutics	Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
EP2750660B1 (en)	2011-08-29	2016-10-12	Mati Therapeutics Inc.	Sustained release delivery of active agents to treat glaucoma and ocular hypertension
BR112014004753A2 (pt)	2011-08-30	2017-03-28	Univ Gent	formulação de liberação de multicamadas
US20130323306A1 (en) *	2012-05-30	2013-12-05	Boston Scientific Scimed, Inc.	Injectable biodegradable particles for controlled therapeutic agent release
EP3233067B1 (en)	2014-12-18	2019-11-06	DSM IP Assets B.V.	Drug delivery system for delivery of acid sensitive drugs
CA3066437A1 (en) *	2017-06-13	2018-12-20	EyePoint Pharmaceuticals, Inc.	Bioerodible drug delivery devices
FR3085841B1 (fr) *	2018-09-14	2020-12-04	Oreal	Procede de preparation de capsules et systeme associe
EP3698841A1 (en) *	2019-02-19	2020-08-26	L'oreal	Injection device
EP4121017A4 (en) *	2020-03-17	2024-07-03	Blaesi, Aron H.	EXPANDABLE, MULTI-EXCIPIENT STRUCTURED DOSAGE FORM FOR EXTENDED ACTIVE INGREDIENT RELEASE

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3630200A (en) *	1969-06-09	1971-12-28	Alza Corp	Ocular insert
US4014335A (en) *	1975-04-21	1977-03-29	Alza Corporation	Ocular drug delivery device
US5091185A (en) *	1990-06-20	1992-02-25	Monsanto Company	Coated veterinary implants
US5378475A (en) *	1991-02-21	1995-01-03	University Of Kentucky Research Foundation	Sustained release drug delivery devices
US5443505A (en) *	1993-11-15	1995-08-22	Oculex Pharmaceuticals, Inc.	Biocompatible ocular implants
US6051576A (en)	1994-01-28	2000-04-18	University Of Kentucky Research Foundation	Means to achieve sustained release of synergistic drugs by conjugation
US5550050A (en) *	1994-04-15	1996-08-27	Cytotherapeutics, Inc.	Method for implanting encapsulated cells in a host
US5518672A (en)	1994-05-31	1996-05-21	Randcastle Extrusion Systems, Inc.	Extrusion surge controller and method
US5486328A (en)	1994-05-31	1996-01-23	Randcastle Extrusion Systems, Inc.	Extrusion surge suppressor and method
US5569429A (en)	1995-05-05	1996-10-29	Randcastle Extrusion Systems, Inc.	Dynamic seal and sealing method
US5773019A (en) *	1995-09-27	1998-06-30	The University Of Kentucky Research Foundation	Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5902598A (en) *	1997-08-28	1999-05-11	Control Delivery Systems, Inc.	Sustained release drug delivery devices
US6476079B1 (en) *	1999-12-23	2002-11-05	Leiras Oy	Devices for the delivery of drugs having antiprogestinic properties
US6375972B1 (en) *	2000-04-26	2002-04-23	Control Delivery Systems, Inc.	Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
SE0001893D0 (sv) *	2000-05-22	2000-05-22	Pharmacia & Upjohn Ab	Medical arrangement
CA2451187C (en) *	2001-06-22	2012-08-14	Southern Biosystems, Inc.	Zero-order prolonged release coaxial implants
AUPR602401A0 (en) *	2001-06-29	2001-07-26	Smart Drug Systems Inc	Sustained release delivery system
AUPR951501A0 (en) *	2001-12-14	2002-01-24	Smart Drug Systems Inc	Modified sustained release pharmaceutical system
WO2003051328A1 (en) *	2001-12-18	2003-06-26	Novo Nordisk A/S	Solid dose micro implant
DK1696822T3 (da)	2003-11-13	2010-05-17	Psivida Inc	Injicerbart vedvarende frigørelsesimplantat, som har en bioeroderbar matrixkerne og en bioeroderbar hus

2004
- 2004-10-26 DK DK04796413.5T patent/DK1696822T3/da active
- 2004-10-26 WO PCT/US2004/035430 patent/WO2005051234A2/en active Application Filing
- 2004-10-26 NZ NZ575950A patent/NZ575950A/en not_active IP Right Cessation
- 2004-10-26 ES ES10156691.7T patent/ES2447816T7/es active Active
- 2004-10-26 JP JP2006539545A patent/JP5661226B2/ja not_active Expired - Lifetime
- 2004-10-26 CA CA2545650A patent/CA2545650C/en not_active Expired - Lifetime
- 2004-10-26 PL PL04796413T patent/PL1696822T3/pl unknown
- 2004-10-26 PT PT101566917T patent/PT2233112E/pt unknown
- 2004-10-26 AT AT04796413T patent/ATE460901T1/de active
- 2004-10-26 NZ NZ581461A patent/NZ581461A/en not_active IP Right Cessation
- 2004-10-26 EP EP10156691.7A patent/EP2233112B3/en not_active Expired - Lifetime
- 2004-10-26 EP EP04796413A patent/EP1696822B1/en not_active Expired - Lifetime
- 2004-10-26 AU AU2004292957A patent/AU2004292957C1/en not_active Expired
- 2004-10-26 NZ NZ547619A patent/NZ547619A/en not_active IP Right Cessation
- 2004-10-26 ES ES04796413T patent/ES2340389T3/es not_active Expired - Lifetime
- 2004-10-26 DE DE602004026106T patent/DE602004026106D1/de not_active Expired - Lifetime
- 2004-10-26 SI SI200431405T patent/SI1696822T1/sl unknown
- 2004-10-26 PL PL10156691T patent/PL2233112T6/pl unknown
- 2004-10-26 PT PT04796413T patent/PT1696822E/pt unknown
- 2004-10-26 MX MXPA06005431A patent/MXPA06005431A/es active IP Right Grant
- 2004-11-05 TW TW093133899A patent/TWI445559B/zh not_active IP Right Cessation
- 2004-11-05 TW TW103107311A patent/TWI496597B/zh not_active IP Right Cessation
2006
- 2006-05-11 IL IL175584A patent/IL175584A/en active IP Right Grant
- 2006-05-23 NO NO20062362A patent/NO20062362L/no unknown
2011
- 2011-03-29 HK HK11103212.3A patent/HK1148931A1/xx not_active IP Right Cessation
- 2011-12-16 JP JP2011275895A patent/JP5526114B2/ja not_active Expired - Lifetime
2013
- 2013-11-19 JP JP2013239238A patent/JP5918195B2/ja not_active Expired - Lifetime
2014
- 2014-02-20 CY CY20141100139T patent/CY1114947T1/el unknown
- 2014-05-20 FR FR14C0042C patent/FR14C0042I1/fr active Active

Also Published As

Publication number	Publication date
CA2545650A1 (en)	2005-06-09
EP1696822B1 (en)	2010-03-17
NZ581461A (en)	2011-04-29
JP2007512248A (ja)	2007-05-17
NO20062362L (no)	2006-08-13
EP2233112B1 (en)	2013-11-20
JP5918195B2 (ja)	2016-05-18
PL2233112T6 (pl)	2014-11-28
EP1696822A2 (en)	2006-09-06
WO2005051234A3 (en)	2005-11-10
ATE460901T1 (de)	2010-04-15
AU2004292957C1 (en)	2011-04-28
HK1148931A1 (en)	2011-09-23
EP2233112B3 (en)	2014-05-14
PT1696822E (pt)	2010-04-28
NZ575950A (en)	2010-06-25
IL175584A (en)	2015-05-31
JP5661226B2 (ja)	2015-01-28
AU2004292957B2 (en)	2010-09-09
TWI445559B (zh)	2014-07-21
PL2233112T3 (pl)	2014-05-30
JP2012072180A (ja)	2012-04-12
DK1696822T3 (da)	2010-05-17
AU2004292957A1 (en)	2005-06-09
DE602004026106D1 (de)	2010-04-29
ES2447816T7 (es)	2014-06-25
PL1696822T3 (pl)	2010-08-31
EP2233112A3 (en)	2011-03-02
ES2340389T3 (es)	2010-06-02
MXPA06005431A (es)	2007-01-25
ES2447816T3 (es)	2014-03-13
TWI496597B (zh)	2015-08-21
PT2233112E (pt)	2014-02-27
TW200526285A (en)	2005-08-16
JP5526114B2 (ja)	2014-06-18
JP2014040479A (ja)	2014-03-06
SI1696822T1 (sl)	2010-07-30
CY1114947T1 (el)	2016-12-14
EP2233112A2 (en)	2010-09-29
TW201422269A (zh)	2014-06-16
CA2545650C (en)	2015-08-18
NZ547619A (en)	2009-06-26
IL175584A0 (en)	2006-09-05
WO2005051234A2 (en)	2005-06-09

Publication	Publication Date	Title
FR14C0042I1 (fr)	2014-06-27	Implant injectable a liberation prolongee comprenant un noyau a matrice bioerodable et un revetement bioerodable
DE69929055T2 (de)	2006-07-20	Verfahren zur spritzgussherstellung von vorrichtungen mit kontrollierter wirkstofffreisetzung und damit hergestellte vorrichtung
AU651084B2 (en)	1994-07-14	Article for the controlled delivery of an active substance, comprising a hollow space fully enclosed by a wall and filled in full or in part with one or more active substances
WO2011012137A3 (en)	2011-06-23	A medical device of polyolefin
Johnson et al.	2021	Drug eluting implants in pharmaceutical development and clinical practice
WO2007041410A3 (en)	2007-07-12	Sustained release small molecule drug formulation
ES2093625T3 (es)	1997-01-01	Administracion extendida de farmaco de moleculas pequeñas solubles en agua.
Duran et al.	2023	3D printing of silicone and polyurethane elastomers for medical device application: A review
CA2484632A1 (en)	2003-11-20	Processes for forming a drug delivery device
DE50103340D1 (de)	2004-09-23	Verfahren zur herstellung aktivstoffhaltiger kapseln mit ultradünner wandschicht
WO2006030431A3 (en)	2006-08-10	Biocompatible drug delivery apparatus and methods
Bagheri et al.	2023	3D Printing of Customized Drug Delivery Systems with Controlled Architecture via Reversible Addition‐Fragmentation Chain Transfer Polymerization
ATE303141T1 (de)	2005-09-15	Ketoprofen mikrogranulat, verfahren zur herstellung desselben sowie pharmazeutische zusammensetzungen
Alkhalaf et al.	2021	Review of polydimethylsiloxane (pdms) as a material for additive manufacturing
ATE398447T1 (de)	2008-07-15	Verwendung von ethanol als weichmacher zur herstellung von subkutanen implantaten , welche in einer plga matrize dispergierte thermolabile wirkstoffe enthalten
IN2012DN04939A (pt)	2015-09-25
Uziel et al.	2019	Three-dimensional printing for drug delivery devices: a state-of-the-art survey
EP2558271A1 (de)	2013-02-20	Kanülenvorrichtung und verfahren und vorrichtung zum bestücken einer kanülenvorrichtung mit einem implantat
Monney et al.	2020	Highly cross-linked, physiologically responsive, mechanically adaptive polymer networks made by photopolymerization
CY1114534T1 (el)	2016-10-05	Συσκευες ενεσιμης χορηγησης με παρατεταμενη αποδεσμευση
Somwanshi et al.	2023	Natural Alternatives to Non-biodegradable Polymers in 3D Printing of Pharmaceuticals
Zheng et al.	2025	Recent Advances in Structural and Functional Design of Electrospun Nanofibers for Wound Healing
CN117677411A (zh)	2024-03-08	延长释放涂层的组合物和应用延长释放涂层的方法
ZA202206046B (en)	2024-08-28	Aerosol-generating element for use in an aerosol-generating article or system
MY135804A (en)	2008-07-31	Processes of forming a drug delivery device